Variable

Renalof^® Group

Placebo Group

P value

n (%)

n (%)

Duration of dysuria, pollakiuria, urinary urgency

2 weeks

75 (62.5%)

0 (0.0%)

<0.001

4 weeks

103 (23.3%)

2 (5.7%)

<0.001

6 weeks or more

120 (14.2%)

17 (42.9%)

<0.001

No variations

0 (0.0%)

18 (51.4%)

<0.001